PAM
FHTX icon

Panagora Asset Management’s Foghorn Therapeutics FHTX Stock Holding History

Panagora Asset Management’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$856K Buy
175,406
+60,343
+52% +$268K ﹤0.01% 773
2026
Q1 		$550K Buy
115,063
+25,768
+29% +$141K ﹤0.01% 829
2025
Q4 		$482K Buy
89,295
+23,958
+37% +$109K ﹤0.01% 880
2025
Q3 		$319K Hold
65,337
– – ﹤0.01% 941
2025
Q2 		$307K Buy
65,337
+11,002
+20% +$46K ﹤0.01% 926
2025
Q1 		$198K Sell
54,335
-819
-1% -$3.73K ﹤0.01% 1048
2024
Q4 		$260K Buy
55,154
+15,913
+41% +$116K ﹤0.01% 1000
2024
Q3 		$365K Sell
39,241
-59,286
-60% -$429K ﹤0.01% 995
2024
Q2 		$567K Sell
98,527
-1,778
-2% -$10.6K ﹤0.01% 882
2024
Q1 		$673K Buy
100,305
+3,288
+3% +$18.3K ﹤0.01% 909
2023
Q4 		$626K Buy
97,017
+62,441
+181% +$269K ﹤0.01% 940
2023
Q3 		$173K Buy
+34,576
New +$267K ﹤0.01% 1189

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
EC
Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Panagora Asset Management's FHTX Position: Q2 2026 in Review

Panagora Asset Management increased its Foghorn Therapeutics (FHTX) stake by 52% in Q2 2026, buying an estimated $268K and bringing the position to 175,406 shares worth $856K. The position accounts for ﹤0.01% of the portfolio, ranked #773.

Panagora Asset Management first reported a position in FHTX in Q3 2023 and has held it in 12 quarters since. 103 funds tracked by Wall St. Rank hold FHTX as of Q2 2026.

  • Panagora Asset Management held 175,406 shares of Foghorn Therapeutics worth $856K as of Q2 2026.
  • Panagora Asset Management bought 60,343 Foghorn Therapeutics shares in Q2 2026, an estimated $268K.
  • Foghorn Therapeutics made up ﹤0.01% of Panagora Asset Management's portfolio in Q2 2026, its #773 holding.
  • Panagora Asset Management first reported a position in Foghorn Therapeutics in Q3 2023 and has held it in 12 quarters since.
  • 103 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q2 2026.

Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.